Mantle Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Mantle Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-08-29Clinical Trial Update: Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
This clinical trial update reports on blood immunophenotyping techniques to aid staging of indolent B-cell lymphomas, including Follicular L…
-
CLINICAL_TRIALS research · 2017-07-19Clinical Trial Update: Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of CT-1530 in relapsed or refractory B-cell non-Hodgkin lymphoma, chronic lymphocyt…
-
CLINICAL_TRIALS research · 2017-03-16Clinical Trial Update: Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma [Phase 1, Phase 2]
This document describes a Phase 1/2 clinical trial evaluating competitive transfer of two αCD19-TCRz-CAR-T cell constructs (one with CD28 an…
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL [Phase 3]
Phase 3 trial evaluating induction regimens R-CHOP vs R-FC, followed by interferon maintenance versus rituximab maintenance in mantle cell l…
-
CLINICAL_TRIALS research · 2016-05-13Clinical Trial Update: Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma [Phase 3]
Phase 3 trial update evaluating rituximab maintenance therapy for CD20-positive aggressive lymphoma and mantle cell lymphoma; no results are…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 [NA]
Clinical trial update describing CART19 therapy for relapsed and/or chemotherapy-refractory B-cell malignancies with an unknown status of th…
-
CLINICAL_TRIALS research · 2015-09-29Clinical Trial Update: Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of a genetically engineered lymphocyte therapy for chemotherapy-resistant or refrac…
-
CLINICAL_TRIALS research · 2014-10-17Clinical Trial Update: Tissue Collection for Biomarkers Determining Resistance to Ibrutinib
Trial update on tissue collection for biomarkers to determine resistance to ibrutinib in mantle cell lymphoma and chronic lymphocytic leukem…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma [Phase 3]
Phase 3 clinical trial comparing chemotherapy followed by radiation therapy and peripheral stem cell transplant versus chemotherapy plus int…
-
CLINICAL_TRIALS research · 2013-08-02Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation in patients with mantle cell lymphoma; current status is unknown.
-
CLINICAL_TRIALS research · 2011-09-13Clinical Trial Update: Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL) [Phase 1, Phase 2]
Clinical trial update on first-line dexamethasone, ofatumumab, and bendamustine (DOT) for mantle cell lymphoma in Phase 1/2, with the trial …
-
CLINICAL_TRIALS research · 2011-03-25Clinical Trial Update: Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating the combination of bortezomib, fludarabine, and cyclophosphamide for recurrent mantle cell lymphoma…
-
CLINICAL_TRIALS research · 2009-07-27Clinical Trial Update: Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma [Phase 2]
A Phase 2 prospective trial investigates immunochemotherapy followed by autologous and allogeneic stem cell transplantation in patients with…
-
CLINICAL_TRIALS research · 2006-10-18Clinical Trial Update: Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma [Phase 2]
This is a Phase 2 clinical trial update for the BORID regimen (bortezomib, rituximab, and dexamethasone) in relapsed/refractory mantle cell …